Evidence map›Paper›PMID 30485280›Full record

ArticlePloS one2018

Tracking a serial killer: Integrating phylogenetic relationships, epidemiology, and geography for two invasive meningococcal disease outbreaks.

Ifeoma Ezeoke, Madeline R Galac, Ying Lin, Alvin T Liem, Pierce A Roth, Andrew Kilianski, Henry S Gibbons, Danielle Bloch, John Kornblum, Paula Del Rosso and 2 more

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Reactive vaccination as control strategy for an outbreak of invasive meningococcal disease caused byEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ifeoma EzeokeBureau of Communicable Disease, Department of Health and Mental Hygiene, New York, NY, United States of America.
Madeline R GalacDepartment of Bioinformatics and Genomics, University of North Carolina, Charlotte, NC, United States of America.
Ying LinBureau of Public Health Laboratory, Department of Health and Mental Hygiene, New York, NY, United States of America.
Alvin T LiemDepartment of Microbiology, US Army Edgewood Chemical and Biological Center, Aberdeen Proving Ground, MD, United States of America.
Pierce A RothDepartment of Microbiology, US Army Edgewood Chemical and Biological Center, Aberdeen Proving Ground, MD, United States of America.
Andrew KilianskiDepartment of Bioinformatics and Genomics, University of North Carolina, Charlotte, NC, United States of America.
Henry S GibbonsDepartment of Microbiology, US Army Edgewood Chemical and Biological Center, Aberdeen Proving Ground, MD, United States of America.
Danielle BlochBureau of Communicable Disease, Department of Health and Mental Hygiene, New York, NY, United States of America.
John KornblumBureau of Public Health Laboratory, Department of Health and Mental Hygiene, New York, NY, United States of America.
Paula Del RossoBureau of Communicable Disease, Department of Health and Mental Hygiene, New York, NY, United States of America.
Daniel A JaniesDepartment of Bioinformatics and Genomics, University of North Carolina, Charlotte, NC, United States of America.
Don WeissBureau of Communicable Disease, Department of Health and Mental Hygiene, New York, NY, United States of America.ORCID 0000-0001-5898-4565

Funding

NCEZID CDC HHS U50 CK000407Wellcome Trust
6 · The paper itself

Abstract

backgroundWhile overall rates of meningococcal disease have been declining in the United States for the past several decades, New York City (NYC) has experienced two serogroup C meningococcal disease outbreaks in 2005-2006 and in 2010-2013. The outbreaks were centered within drug use and sexual networks, were difficult to control, and required vaccine campaigns.

methodsWhole Genome Sequencing (WGS) was used to analyze preserved meningococcal isolates collected before and during the two outbreaks. We integrated and analyzed epidemiologic, geographic, and genomic data to better understand transmission networks among patients. Betweenness centrality was used as a metric to understand the most important geographic nodes in the transmission networks. Comparative genomics was used to identify genes associated with the outbreaks.

resultsNeisseria meningitidis serogroup C (ST11/ET-37) was responsible for both outbreaks with each outbreak having distinct phylogenetic clusters. WGS did identify some misclassifications of isolates that were more distant from the outbreak strains, as well as those that should have been included based on high genomic similarity. Genomes for the second outbreak were more similar than the first and no polymorphism was found to either be unique or specific to either outbreak lineage. Betweenness centrality as applied to transmission networks based on phylogenetic analysis demonstrated that the outbreaks were transmitted within focal communities in NYC with few transmission events to other locations.

conclusionsNeisseria meningitidis is an ever changing pathogen and comparative genomic analyses can help elucidate how it spreads geographically to facilitate targeted interventions to interrupt transmission.

Indexed as

Disease OutbreaksPhylogenyAdolescentAdultAgedChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleMeningococcal InfectionsMiddle AgedNeisseria meningitidis, Serogroup CNew York City

Identifiers

PMID30485280
PMCPMC6261407

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.